Matinas BioPharma to Present at the 2017 Jefferies Global Healthcare Conference
Jun 01, 2017 11:28 am UTC| Business
BEDMINSTER, N.J., June 01, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that...
Matinas BioPharma to Present at the 2017 Jefferies Global Healthcare Conference
Jun 01, 2017 11:28 am UTC| Business
BEDMINSTER, N.J., June 01, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that...
Matinas BioPharma to Present at the 2017 Jefferies Global Healthcare Conference
Jun 01, 2017 11:28 am UTC| Business
BEDMINSTER, N.J., June 01, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that...
Matinas BioPharma to Present at the 2017 Jefferies Global Healthcare Conference
Jun 01, 2017 11:28 am UTC| Business
BEDMINSTER, N.J., June 01, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that...
Matinas BioPharma to Present at the 2017 Jefferies Global Healthcare Conference
Jun 01, 2017 11:28 am UTC| Business
BEDMINSTER, N.J., June 01, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that...
Matinas BioPharma to Present at the 2017 Jefferies Global Healthcare Conference
Jun 01, 2017 11:28 am UTC| Business
BEDMINSTER, N.J., June 01, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that...
Matinas BioPharma to Present at the 2017 Jefferies Global Healthcare Conference
Jun 01, 2017 11:28 am UTC| Business
BEDMINSTER, N.J., June 01, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows